U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne

U.S. Commercial Launch of Cash-Pay Product Anticipated in Mid-2019 DULUTH, Ga., Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced that the U... Devices, Dermatology, FDA Sebacia, Sebacia Microparticles, acne
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news